Showing results (2361-2370 of 9,904) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|November 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.Bone Marrow Transplantation|November 14, 2025
Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host diseaseHannah Choe, Zachariah DeFilippBone Marrow Transplantation|June 2, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL studyGianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, et al.Bone Marrow Transplantation|May 28, 2025
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working partyNour Moukalled, Allain-Thibeault Ferhat, Ali Bazarbachi, et al.Bone Marrow Transplantation|July 24, 2025
Outcomes of hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia: a multicenter Brazilian cohort studyDaniela Morales, Gisele Loth, Vergílio Antonio Rensi Colturato, et al.Bone Marrow Transplantation|May 5, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelinesAqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad, et al.Bone Marrow Transplantation|May 3, 2025
Mechanisms underlying seizures and hypothermia during busulphan administrationIbrahim El-Serafi, Sofia Berglund, Fadwa BenKessou, et al.Bone Marrow Transplantation|October 6, 2025
Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective studyLiang-Piu Koh, Yeh Ching Linn, Yang Liang Boo, et al.Bone Marrow Transplantation|October 1, 2025
Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCTRadwan Massoud, Evgeny Klyuchnikov, Normann Steiner, et al.Bone Marrow Transplantation|September 27, 2025
Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complicationPanagiotis Tsirigotis, Ioanna LazanaPageof 991